Shock therapy for pelvic pain? TENS device trial targets endometriosis
NCT ID NCT07393295
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a small electrical device (TENS) can reduce pelvic pain in women with endometriosis or adenomyosis. 92 women on stable hormone therapy will use the device for 45 minutes daily over 4 weeks, rating their pain on a scale. The goal is to see if the device lowers average pain scores compared to a sham treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- TENS device (transcutaneous electrical nerve stimulation)
- What this could lead to
- If it works, this could offer a drug-free option to manage endometriosis pain at home.
- What could go wrong
- This is a small, early-stage trial with no blinding for the device. Pain is subjective, and results may not apply to all women with endometriosis.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
IFEM Endo, Clinique Tivoli-Ducos
RECRUITINGBordeaux, 33000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can yoga ease the pain of endometriosis after surgery?
- Building a biological treasure trove to decode Women's health mysteries
- Gaming for health: could a video game empower endometriosis patients?
- Can a new formulation of an endometriosis drug match the standard?
- Can a glowing dye reveal a Woman's fertility after ovarian cyst surgery?
- Can we predict endometriosis recurrence and fertility outcomes?